Medicis Pharmaceutical Corp (NYSE:MRX)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.

Recs

0
Player Avatar 3PO (89.37) Submitted: 10/6/2007 11:10:00 AM : Outperform Start Price: $28.82 MRX Score: +39.06

S&P Fair Value @28.50

Featured Broker Partners


Advertisement